128 related articles for article (PubMed ID: 3746808)
1. A stereochemical explanation of the dopamine agonist and antagonist activity of stereoisomeric pairs.
Froimowitz M; Neumeyer JL; Baldessarini RJ
J Med Chem; 1986 Sep; 29(9):1570-3. PubMed ID: 3746808
[No Abstract] [Full Text] [Related]
2. (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist.
Hillver SE; Björk L; Li YL; Svensson B; Ross S; Andén NE; Hacksell U
J Med Chem; 1990 Jun; 33(6):1541-4. PubMed ID: 2140413
[No Abstract] [Full Text] [Related]
3. Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
Neumeyer JL; Froimowitz M; Baldessarini RJ; Campbell A; Gao YG
J Recept Res; 1988; 8(1-4):83-96. PubMed ID: 3385694
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
Johansson AM; Fredriksson K; Hacksell U; Grol CJ; Svensson K; Carlsson A; Sundell S
J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
Johansson AM; Karlén A; Grol CJ; Sundell S; Kenne L; Hacksell U
Mol Pharmacol; 1986 Sep; 30(3):258-69. PubMed ID: 2943981
[TBL] [Abstract][Full Text] [Related]
6. The conformation of dopamine at its receptor: binding of monohydroxy-2-aminotetralin enantiomers and positional isomers.
Tedesco JL; Seeman P; McDermed JD
Mol Pharmacol; 1979 Sep; 16(2):369-81. PubMed ID: 514252
[No Abstract] [Full Text] [Related]
7. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
[No Abstract] [Full Text] [Related]
8. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.
Arvidsson LE; Hacksell U; Nilsson JL; Hjorth S; Carlsson A; Lindberg P; Sanchez D; Wikstrom H
J Med Chem; 1981 Aug; 24(8):921-3. PubMed ID: 6460101
[No Abstract] [Full Text] [Related]
9. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
[TBL] [Abstract][Full Text] [Related]
10. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors.
Svensson K; Hjorth S; Clark D; Carlsson A; Wikström H; Andersson B; Sanchez D; Johansson AM; Arvidsson LE; Hacksell U
J Neural Transm; 1986; 65(1):1-27. PubMed ID: 3083041
[TBL] [Abstract][Full Text] [Related]
11. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
Johansson AM; Nilsson JL; Karlén A; Hacksell U; Sanchez D; Svensson K; Hjorth S; Carlsson A; Sundell S; Kenne L
J Med Chem; 1987 Oct; 30(10):1827-37. PubMed ID: 3656358
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
Wilson J; Lin H; Fu D; Javitch JA; Strange PG
J Neurochem; 2001 Apr; 77(2):493-504. PubMed ID: 11299312
[TBL] [Abstract][Full Text] [Related]
13. Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative.
Karlén A; Johansson AM; Kenne L; Arvidsson LE; Hacksell U
J Med Chem; 1986 Jun; 29(6):917-24. PubMed ID: 3712382
[TBL] [Abstract][Full Text] [Related]
14. II. Pharmacological studies with derivatives of 2-aminotetralin, benzhydro[f]quinoline, benzhydro[g]quinoline, apomorphine and clonidine suggest a pharmacological dissimilarity between peripheral presynaptic dopamine receptors and alpha-2 adrenoceptors.
Maixner W; Flynn JR; Arnerić SP; Cannon JG; Long JP
J Pharmacol Exp Ther; 1983 Feb; 224(2):352-8. PubMed ID: 6296357
[TBL] [Abstract][Full Text] [Related]
15. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
16. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H
J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131
[TBL] [Abstract][Full Text] [Related]
17. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
[TBL] [Abstract][Full Text] [Related]
18. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
[TBL] [Abstract][Full Text] [Related]
19. Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232.
Cooper SJ; Rusk IN; Barber DJ
Physiol Behav; 1989 Jun; 45(6):1263-6. PubMed ID: 2573095
[TBL] [Abstract][Full Text] [Related]
20. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
